Skip to main content
Premium Trial:

Request an Annual Quote

Bowel Disease Group Will Use Illumina s BeadChip for IBD Study

NEW YORK, Jan .12 (GenomeWeb News) - The NIDDK Inflammatory Bowel Disease Genetics Consortium will use the Sentrix HumanHap300 BeadChips and Infinium assay reagents for a genome-wide study, Illumina said today.

 

The consortium will genotype over 2,000 case-control samples to help identify genetic variants that increase susceptibility to Crohn's disease.

 

One thousand control individuals will be typed as part of the study, and the control genotypes will be made available to the scientific community.

 

The genotyping will be performed at The Feinstein Institute for Medical Research, part of the North Shore-Long Island Jewish Health System.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.